Steve Kirsch's newsletter β’ 6 implied HN points β’ 20 Nov 25
- Denmark is seen as a good place for vaccine studies because its diagnosis process for autism is much slower than in other countries. This means many cases are diagnosed later, making it look like there is less of a problem.
- The vaccination schedule in Denmark is different, with fewer vaccines given to infants. This might cause developmental issues to show up later, skewing the data in studies that don't account for these differences.
- Using Danish data in studies can give a false impression of low autism rates. The delays in diagnosis make it seem like there are fewer cases than there actually are, which could mislead conclusions about the effects of vaccines.